US approves $40 generic HIV prevention shot for 120 Countries

The United States Food and Drug Administration (FDA) has approved a generic version of lenacapavir, a long-acting HIV prevention injection administered twice a year, in a major development expected to improve access to affordable HIV prevention medication in 120 low- and middle-income countries.